Navigation Links
Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis

ent of inflammatory bowel disease rats with HMPL-004 caused a significant drop in plasma cytokine concentrations, including TNF-? and IL-1?. Pre-clinical trails for HMPL-004 have shown the almost total restoration of the inner lining of the gut.

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. Chi-Med is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients.

Hutchison MediPharma is Chi-Med’s wholly-owned drug R&D subsidiary and has a team of around 120 scientists and staff focusing on botanical drugs, semi-synthetic natural product drugs, and synthetic single chemical entity drugs. It currently has two candidates in clinical development in both the US and China. HMPL-002, a radiosensitiser for head and neck and non-small cell lung cancer, is in Phase I/II in the US and in proof-of-concept in China. HMPL-004, an inhibitor to a group of inflammatory cytokines, has completed a Phase II proof-of-concept study in Ulcerative Colitis and is in Phase II studies in Crohn’s Disease in the US. Hutchison MediPharma also has a pipeline of single molecular entity discovery projects in auto-immune/inflammatory diseases and oncology therapeutic areas, which have shown activity against clinically validated targets.






Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/10/2014)... July 10, 2014 Decision Resources Group finds ... the U.S. Food and Drug Administration,s (FDA) approval of ... Velphoro, which was approved by the FDA in November ... disease (CKD) patients on dialysis. Other key ... (US) Q2 2014 : ...
(Date:1/15/2014)... 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced ... Global Industry Analysis, Size, Share, Growth, Trends And Forecast, ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... patients in order to treat dental impairments, for tooth ...
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... The End of Polio Concert, funded by the ... 2011, in Perth Australia, has resulted in an unprecedented ... The highly publicized and critically acclaimed concert, which ... Polio Eradication Initiative, has resulted in contributions of $50 ...
... Conn., Nov. 7, 2011 Planet Biopharmaceuticals, Inc. and ... specialty pharmaceutical company focused on providing products for allergy ... an asset sale of ALLERGY CONTROL PRODUCTS, INC., a ... Jersey limited liability company. Theron E. Odlaug, ...
Cached Medicine Technology:Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio 2Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio 3Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio 4
(Date:7/13/2014)... 2014 The Pearland, Texas location of The ... from four months to 12 years of age that offers ... birthday parties and Summer Camps, is now under new ownership. ... Pearland after spending over six years at The Little ... Director. , Berry has over ten years of experience ...
(Date:7/13/2014)... July 13, 2014 The federal court ... ) filed against Johnson & Johnson’s Ethicon, Inc. ... which is expected to get underway next month. According ... U.S. District Court, Southern District of West Virginia on ... on August 7, 2014 at 3:00 p.m. July selection ...
(Date:7/13/2014)... Max International has recently ... be the featured guest at its Charity Exhibition and ... Attendees will learn about Max’s health products and ... basketball games and perform in a 3 point shoot-out. ... and energy-boosting supplements , has recently announced former NBA ...
(Date:7/13/2014)... Fadhits.com is popular among worldwide women. Its lace ... Recently, the company has announced its new selection of ... all these outfits are available at discounted prices (from ... supplier is now offering similar discounts for many other ... many other designs for sale, including flower girl dresses, ...
(Date:7/13/2014)... ANGELES A noninvasive optical imaging device developed ... that later occur in the brain and are ... preliminary results from investigators conducting a clinical trial ... findings July 15 in an oral presentation at ... Denmark. They also were invited by conference organizers ...
Breaking Medicine News(10 mins):Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3
... -- Most children born with HIV infection now survive ... death that awaited HIV-infected babies years ago, researchers report. ... AIDS-causing virus, to better understand the effects of treatment ... these kids, at this point, don,t have virus detectable ...
... Associations for Dental Research (IADR/AADR) have published two studies ... income individuals. These articles, titled "Income-related Inequalities in Dental ... and "Income Inequality and Tooth Loss in the United ... in the Journal of Dental Research, the official publication ...
... By Dennis Thompson HealthDay Reporter , ... and the American Heart Association have put forth an ... attack, stroke and coronary heart disease. The goals ... and illness, however. They place even greater emphasis on ...
... Columbia Business School is proud to announce that Frank ... Finance and Economics and the Healthcare and Pharmaceutical Management ... by the Emerald Literati Network. The award recognizes an ... book series published by Emerald Group Publishing, a leading ...
... , FRIDAY, April 22 (HealthDay News) -- Lynne Braun spends a ... by their hearts and their health. Braun, who works as ... teaches at the university,s College of Nursing, helps counsel people who ... who,ve had a heart attack or stroke and hope to ...
... Healthcare today teleconferenced one of the world,s first live ... to conference attendees in Sao Paolo, Brazil. The meeting, ... of the globe,s largest vascular surgery events and includes ... an endograft device called a repositionable endoprosthesis. ...
Cached Medicine News:Health News:HIV Kids Growing Up Well, Study Finds 2Health News:IADR/AADR Journal of Dental Research releases studies on oral health inequalities in older people 2Health News:To Get Americans Healthier, U.S. Targets the Heart 2Health News:To Get Americans Healthier, U.S. Targets the Heart 3Health News:To Get Americans Healthier, U.S. Targets the Heart 4Health News:Columbia business school’s Frank Lichtenberg awarded by the Emerald Literati Network 2Health News:Nurse Practitioner Counsels Lifestyle Changes as Key to Heart Health 2Health News:Nurse Practitioner Counsels Lifestyle Changes as Key to Heart Health 3Health News:Scott & White Healthcare broadcasts live surgery to São Paolo, Brazil 2
... Maximum Xtra, and Maximum ACT introducers ... and specialty hemostasis introducers in the ... premier hemostasis introducers for use in ... angiography, angioplasty, stenting, atherectomy, temporary pacing, ...
St. Jude Medical's line of guiding introducers includes Swartz Series, SAFL, SEPT, CSTA, RAMP, and 2 piece steerable...
The intended use of the percutaneous PREFACE Guiding Sheath is for the introduction of intravascular electrophysiology catheters into any cardiac chamber....
... EP Systems sells the popular transeptal ... needles. These products allow left atrial ... catheter ablation of left-sided arrhythmogenic substrates. ... others use it when a transaortic ...
Medicine Products: